Mechanisms of bacterial virulence in pulmonary infections

Current Opinion in Critical Care

Volumn 16, Issue 1, 2010, Pages 8-12

  Moskowitz, Samuel M ^a,b   Wiener Kronish, Jeanine P ^a,b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADHESIN; ALPHA HEMOLYSIN; ALPHA TOXIN; CHOLERA TOXIN; DBPA ADHESIN; DOXYCYCLINE; FREUND ADJUVANT; LIVE VACCINE; LUKF PV BACTERIAL TOXIN; LUKS PV BACTERIAL TOXIN; METICILLIN; MINOCYCLINE; PANTON VALENTINE LEUKOCIDIN; QUINOLONE DERIVATIVE; TETRACYCLINE; UNCLASSIFIED DRUG;

ANTIBIOTIC RESISTANCE; BACTEREMIA; BACTERIAL COLONIZATION; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BACTERIUM DETECTION; CLINICAL RESEARCH; COMMUNITY; COMPREHENSION; FRANCISELLA TULARENSIS; GENE CONTROL; GENETIC ANALYSIS; GENOMICS; HORIZONTAL GENE TRANSFER; HOST; HOST SUSCEPTIBILITY; HUMAN; IMMUNE SYSTEM; IMMUNIZATION; INOCULATION; LEUKOCYTE; LIFE; LUNG INFECTION; LUNG INJURY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; MOLECULAR EVOLUTION; NASOPHARYNX; NONHUMAN; NORTH AMERICA; PATHOGENESIS; PNEUMONIA; REVIEW; SPECIES; STAPHYLOCOCCUS INFECTION; SUBSPECIES;

BACTERIAL TOXINS; DRUG RESISTANCE, BACTERIAL; EXOTOXINS; FRANCISELLA TULARENSIS; GENE TRANSFER, HORIZONTAL; HUMANS; INTENSIVE CARE; LEUKOCIDINS; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; PNEUMONIA; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS;

EID: 75149146621     PISSN: 10705295     EISSN: 15317072     Source Type: Journal    
DOI: 10.1097/MCC.0b013e3283354710     Document Type: Review

References (33)

1. Pittet JF, Matthay MA, Pier G, et al. Pseudomonas aeruginosa-induced lung and pleural injury in sheep. Differential protective effect of circulating versus alveolar immunoglobulin G antibody J Clin Invest 1993; 92:1221-1228.
2. Pittet JF, Wiener-Kronish JP, Serikov V, Matthay MA. Resistance of the alveolar epithelium to injury from septic shock in sheep. Am J Respir Crit Care Med 1995; 151:1093-1100.
3. Wiener-Kronish JP, Albertine KH, Matthay MA. Differential responses of the endothelial and epithelial barriers of the lung in sheep to Escherichia coli endotoxin. J Clin Invest 1991; 88:864-875.
4. Aberle DR, Wiener-Kronish JP, Webb WR, Matthay MA. Hydrostatic versus increased permeability pulmonary edema: diagnosis based on radiographic criteria in critically ill patients. Radiology 1988; 168:73-79.
5. Klevens RM, Morrison MA, Nadle J, et al. Invasive methicillin-resistant Staphylococcus aureus infections in the United States. JAMA 2007; 298:1763-1771.
6. Chambers HF, Deleo FR. Waves of resistance: Staphylococcus aureus in the antibiotic era. Nat Rev Microbiol 2009; 7:629-641.
7. Labandeira-Rey M, Couzon F, Boisset S, et al. Staphylococcus aureus Panton-Valentine leukocidin causes necrotizing pneumonia. Science 2007; 315:1130-1133. (Pubitemid 46328024)
8. Bubeck Wardenburg J, Palazzolo-Ballance AM, Otto M, et al. Panton- Valentine leukocidin is not a virulence determinant in murine models of community-associated methicillin-resistant Staphylococcus aureus disease. J Infect Dis 2008; 198:1166-1170.
9. Miles G, Movileanu L, Bayley H. Subunit composition of a bicomponent toxin: staphylococcal leukocidin forms an octameric transmembrane pore. Protein Sci 2002; 11:894-902.
10. Diep BA, Palazzolo-Ballance AM, Tattevin P, et al. Contribution of Panton- Valentine leukocidin in community-associated methicillin-resistant Staphylococcus aureus pathogenesis. PLoS ONE 2008; 3:e3198.
11. Szmigielski S, Prevost G, Monteil H, et al. Leukocidal toxins of staphylococci. Zentralbl Bakteriol 1999; 289:185-201.
12. Szmigielski S, Jeljaszewicz J, Wilczynski J, Korbecki M. Reaction of rabbit leucocytes to staphylococcal (Panton-Valentine) leucocidin in vivo. J Pathol Bacteriol 1966; 91:599-604.
13. Diep BA, Chambers HF, Graber CJ, et al. Emergence of multidrug-resistant, community-associated, methicillin-resistant Staphylococcus aureus clone USA300 in men who have sex with men. Ann Intern Med 2008; 148:249-257.
14. Colin DA, Monteil H. Control of the oxidative burst of human neutrophils by staphylococcal leukotoxins. Infect Immun 2003; 71:3724-3729.
15. Konig B, Koller M, Prevost G, et al. Activation of human effector cells by different bacterial toxins (leukocidin, alveolysin, and erythrogenic toxin A): generation of interleukin-8. Infect Immun 1994; 62:4831-4837.
16. Konig B, Prevost G, Piemont Y, Konig W. Effects of Staphylococcus aureus leukocidins on inflammatory mediator release from human granulocytes. J Infect Dis 1995; 171:607-613.
17. Montgomery CP, Daum RS. Transcription of inflammatory genes in the lung after infection with community-associated methicillin-resistant Staphylococcus aureus: a role for Panton-Valentine leukocidin? Infect Immun 2009; 77:2159-2167.
18. Voyich JM, Otto M, Mathema B, et al. Is Panton-Valentine leukocidin the major virulence determinant in community-associated methicillin-resistant Staphylococcus aureus disease? J Infect Dis 2006; 194:1761-1770.
19. Bubeck Wardenburg J, Bae T, Otto M, et al. Poring over pores: alphahemolysin and Panton-Valentine leukocidin in Staphylococcus aureus pneumonia. Nat Med 2007; 13:1405-1406.
20. Bubeck Wardenburg J, Patel RJ, Schneewind O. Surface proteins and exotoxins are required for the pathogenesis of Staphylococcus aureus pneumonia. Infect Immun 2007; 75:1040-1044.
21. Kennedy AD, Otto M, Braughton KR, et al. Epidemic community-associated methicillin-resistant Staphylococcus aureus: recent clonal expansion and diversification. Proc Natl Acad Sci U S A 2008; 105:1327-1332.
22. Brown EL, Dumitrescu O, Thomas D, et al. The Panton-Valentine leukocidin vaccine protects mice against lung and skin infections caused by Staphylococcus aureus USA300. Clin Microbiol Infect 2009; 15:156-164.
23. Bubeck Wardenburg J, Schneewind O. Vaccine protection against Staphylococcus aureus pneumonia. J Exp Med 2008; 205:287-294.
24. Menzies BE, Kernodle DS. Passive immunization with antiserum to a nontoxic alpha-toxin mutant from Staphylococcus aureus is protective in a murine model. Infect Immun 1996; 64:1839-1841.
25. Schwartz BS, Graber CJ, Diep BA, et al. Doxycycline, not minocycline, induces its own resistance in multidrug-resistant, community-associated methicillin-resistant Staphylococcus aureus clone USA300. Clin Infect Dis 2009; 48:1483-1484.
26. Tattevin P, Basuino L, Chambers HF. Subinhibitory fluoroquinolone exposure selects for reduced beta-lactam susceptibility in methicillin-resistant Staphylococcus aureus and alterations in the SOS-mediated response. Res Microbiol 2009; 160:187-192.
27. Champion MD, Zeng Q, Nix EB, et al. Comparative genomic characterization of Francisella tularensis strains belonging to low and high virulence subspecies. PLoS Pathog 2009; 5:e1000459.
28. Bandouchova H, Sedlackova J, Pohanka M, et al. Tularemia induces different biochemical responses in BALB/c mice and common voles. BMC Infect Dis 2009; 9:101.
29. Raymond CR, Conlan JW. Differential susceptibility of Sprague-Dawley and Fischer 344 rats to infection by Francisella tularensis. Microb Pathog 2009; 46:231-234.
30. Geisbert TW, Hensley LE, Larsen T, et al. Pathogenesis of Ebola hemorrhagic fever in cynomolgus macaques: evidence that dendritic cells are early and sustained targets of infection. Am J Pathol 2003; 163:2347-2370.
31. Bosio CM, Bielefeldt-Ohmann H, Belisle JT. Active suppression of the pulmonary immune response by Francisella tularensis Schu4. J Immunol 2007; 178:4538-4547.
32. BroekhuijsenM, Larsson P, Johansson A, et al. Genome-wide DNA microarray analysis of Francisella tularensis strains demonstrates extensive genetic conservation within the species but identifies regions that are unique to the highly virulent F. tularensis subsp. tularensis. J Clin Microbiol 2003; 41:2924-2931.
33. KuoLee R, Harris G, Conlan JW, Chen W. Oral immunization of mice with the live vaccine strain (LVS) of Francisella tularensis protects mice against respiratory challenge with virulent type A F. tularensis. Vaccine 2007; 25:3781-3791.